Future Link Network Co Ltd
TSE:9241
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Future Link Network Co Ltd
TSE:9241
|
JP |
|
S
|
Shanghai Kindly Medical Instruments Co Ltd
HKEX:1501
|
CN |
|
D
|
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
K
|
Kaushalya Infrastructure Development Corporation Ltd
NSE:KAUSHALYA
|
IN |
Balance Sheet
Balance Sheet Decomposition
Future Link Network Co Ltd
Future Link Network Co Ltd
Balance Sheet
Future Link Network Co Ltd
| Aug-2019 | Aug-2020 | Aug-2021 | Aug-2022 | Aug-2023 | Aug-2024 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
26
|
167
|
570
|
408
|
368
|
439
|
489
|
|
| Cash Equivalents |
26
|
167
|
570
|
408
|
368
|
439
|
489
|
|
| Total Receivables |
184
|
148
|
157
|
119
|
141
|
164
|
184
|
|
| Accounts Receivables |
165
|
139
|
147
|
105
|
141
|
164
|
184
|
|
| Other Receivables |
19
|
9
|
10
|
13
|
0
|
0
|
0
|
|
| Inventory |
3
|
1
|
2
|
1
|
2
|
3
|
4
|
|
| Other Current Assets |
21
|
33
|
25
|
51
|
34
|
54
|
62
|
|
| Total Current Assets |
234
|
349
|
754
|
579
|
545
|
660
|
739
|
|
| PP&E Net |
31
|
35
|
30
|
32
|
84
|
109
|
103
|
|
| PP&E Gross |
31
|
35
|
30
|
32
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
8
|
12
|
17
|
20
|
0
|
0
|
0
|
|
| Intangible Assets |
23
|
23
|
22
|
31
|
34
|
45
|
63
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Note Receivable |
23
|
25
|
23
|
20
|
18
|
20
|
19
|
|
| Long-Term Investments |
0
|
0
|
0
|
53
|
53
|
53
|
53
|
|
| Other Long-Term Assets |
7
|
13
|
16
|
1
|
13
|
17
|
13
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Total Assets |
318
N/A
|
444
+40%
|
845
+90%
|
714
-16%
|
747
+5%
|
904
+21%
|
994
+10%
|
|
| Liabilities | ||||||||
| Accounts Payable |
65
|
48
|
62
|
44
|
54
|
40
|
43
|
|
| Accrued Liabilities |
31
|
41
|
53
|
22
|
26
|
29
|
25
|
|
| Short-Term Debt |
50
|
50
|
50
|
50
|
75
|
50
|
50
|
|
| Current Portion of Long-Term Debt |
17
|
23
|
32
|
32
|
31
|
48
|
63
|
|
| Other Current Liabilities |
116
|
126
|
178
|
198
|
260
|
281
|
371
|
|
| Total Current Liabilities |
280
|
286
|
375
|
347
|
447
|
448
|
552
|
|
| Long-Term Debt |
60
|
141
|
109
|
76
|
49
|
193
|
135
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
17
|
17
|
22
|
|
| Other Liabilities |
9
|
8
|
8
|
8
|
8
|
8
|
8
|
|
| Total Liabilities |
348
N/A
|
435
+25%
|
492
+13%
|
431
-12%
|
520
+21%
|
666
+28%
|
716
+8%
|
|
| Equity | ||||||||
| Common Stock |
135
|
135
|
267
|
267
|
272
|
277
|
283
|
|
| Retained Earnings |
214
|
174
|
95
|
166
|
233
|
230
|
202
|
|
| Additional Paid In Capital |
49
|
49
|
181
|
182
|
187
|
192
|
197
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
30
N/A
|
9
N/A
|
353
+3 750%
|
283
-20%
|
226
-20%
|
238
+5%
|
278
+17%
|
|
| Total Liabilities & Equity |
318
N/A
|
444
+40%
|
845
+90%
|
714
-16%
|
747
+5%
|
904
+21%
|
994
+10%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|